| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.5 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.032 | 0.6 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.6 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.6 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |